Get notified when PTIX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — The company explicitly states substantial doubt about its ability to continue as a going concern, and the auditor's report includes a going-concern explanatory paragraph.
- Nasdaq Delisting (new) — The company is non-compliant with Nasdaq's minimum stockholders' equity and bid price requirements and is appealing delisting determinations, with a hearing scheduled for January 30, 2025.
- Single-asset Dependence (new) — The company's entire pipeline is built around a single preclinical lead compound, PT00114, which is in-licensed from the University of Toronto and subject to diligence obligations.
- Key Person Dependence (new) — The company has no employment agreements with its executive officers and is highly dependent on specific individuals, including the Chairman and Chief Scientific Advisor.
Protagenic Therapeutics registers resale of 5.84M shares by selling stockholders; company gets no proceeds
Filed December 27, 2024 · ~1 min read
Key Changes
-
high
This is a secondary offering: all 5,844,885 shares are sold by existing investors, and Protagenic receives no proceeds from those sales.
The Offering verify on EDGAR → -
medium
The company may receive cash only if warrants are exercised; any such proceeds would be used for working capital.
Use of Proceeds verify on EDGAR → -
high
Protagenic has no approved products, no product revenue, and an accumulated deficit of $34,749,473 as of September 30, 2024.
Risk Factors verify on EDGAR →
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
Partner
Trade PTIX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify